Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01003444 · ClinicalTrials.gov registry record · Phase 1
Muscle Malonyl Coa Biomarker Assay Development
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01003444 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 4 participants.
The verdict
NCT01003444, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Biopsies of the outer thigh muscle and serum samples will be collected from untreated healthy subjects. These biological samples will be provided to the Diabetes Research Unit Translational Biomarker Laboratory for use in developing and validating human muscle malonyl CoA and serum malonate biomarker assays.
Interventions
- PROCEDURE Muscle biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-11 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01003444
The ClinicalTrials.gov registry entry for NCT01003444 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Muscle biopsy is the first listed.
NCT01003444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01003444 about?
NCT01003444 is a clinical study titled "Muscle Malonyl Coa Biomarker Assay Development". Biopsies of the outer thigh muscle and serum samples will be collected from untreated healthy subjects. These biological samples will be provided to the Diabetes Research Unit Translational Biomarker Laboratory for use in developing and validating human muscle malonyl CoA and serum malonate biomarke...
What is the current status of trial NCT01003444?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2009-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01003444?
The interventions under investigation include: Muscle biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01003444?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.